Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$552M |
| 2 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$519M |
| 3 |
Microsoft
MSFT
|
+$417M |
| 4 |
Apple
AAPL
|
+$376M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$304M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.4B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$396M |
| 3 |
Estee Lauder
EL
|
+$326M |
| 4 |
TSG
The Stars Group Inc.
TSG
|
+$302M |
| 5 |
S&P Global
SPGI
|
+$283M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.93% |
| 2 | Financials | 5.77% |
| 3 | Consumer Discretionary | 5.25% |
| 4 | Healthcare | 5.08% |
| 5 | Communication Services | 4.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AVNS
4226
DELISTED
Avanos Medical
AVNS
| $496K | ﹤0.01% |
16,888
+1,407
| +9% | +$40.7K |
|
|
GAM
4227
General American Investors Company
GAM
$1.56B
| $496K | ﹤0.01% |
15,588
+324
| +2% | +$9.83K |
|
|
DCP
4228
PUT
DELISTED
DCP Midstream, LP
DCP
| $496K | ﹤0.01% |
43,900
+7,400
| +20% | +$70.1K |
|
4229
Simply Good Foods
SMPL
$901M
| $495K | ﹤0.01% |
26,625
+1,386
| +5% | +$24.6K |
|
4230
Victory Capital Holdings
VCTR
$6.19B
| $495K | ﹤0.01% |
28,794
+28,791
| +959,700% | +$452K |
|
4231
Clarus
CLAR
$123M
| $494K | ﹤0.01% |
42,755
+37,051
| +650% | +$376K |
|
4232
CALL
Harmony Gold Mining
HMY
$9.84B
| $494K | ﹤0.01% |
118,400
+55,300
| +88% | +$182K |
|
4233
Bloomin' Brands
BLMN
$741M
| $493K | ﹤0.01% |
46,245
-59,103
| -56% | -$612K |
|
4234
Varex Imaging
VREX
$472M
| $493K | ﹤0.01% |
32,556
+13,428
| +70% | +$271K |
|
|
VBTX
4235
DELISTED
Veritex Holdings
VBTX
| $492K | ﹤0.01% |
27,794
+13,064
| +89% | +$212K |
|
4236
Core Laboratories
CLB
$488M
| $491K | ﹤0.01% |
24,188
+17,043
| +239% | +$305K |
|
4237
Pathward Financial
CASH
$1.86B
| $490K | ﹤0.01% |
26,962
+16,445
| +156% | +$288K |
|
4238
Amphastar Pharmaceuticals
AMPH
$879M
| $488K | ﹤0.01% |
21,718
+6,023
| +38% | +$110K |
|
4239
Newmark Group
NMRK
$2.66B
| $488K | ﹤0.01% |
100,371
-15,726
| -14% | -$66.1K |
|
4240
Seacoast Banking Corp of Florida
SBCF
$3.36B
| $488K | ﹤0.01% |
23,908
+8,571
| +56% | +$174K |
|
4241
Lakeland Financial Corp
LKFN
$1.56B
| $487K | ﹤0.01% |
10,459
-2,182
| -17% | -$89.2K |
|
4242
Worthington Enterprises
WOR
$2.75B
| $487K | ﹤0.01% |
21,159
+474
| +2% | +$8.46K |
|
|
WIRE
4243
DELISTED
Encore Wire Corp
WIRE
| $486K | ﹤0.01% |
9,960
+3,004
| +43% | +$138K |
|
|
TBI
4244
Trueblue
TBI
$215M
| $483K | ﹤0.01% |
31,640
+6,151
| +24% | +$91.3K |
|
4245
Nuveen Quality Municipal Income Fund
NAD
$2.74B
| $482K | ﹤0.01% |
34,383
+2,855
| +9% | +$38.9K |
|
4246
O-I Glass
OI
$1.1B
| $482K | ﹤0.01% |
53,658
+25,117
| +88% | +$194K |
|
4247
Southside Bancshares
SBSI
$967M
| $482K | ﹤0.01% |
17,384
+6,958
| +67% | +$198K |
|
4248
TFS Financial
TFSL
$5.16B
| $482K | ﹤0.01% |
33,734
+14,518
| +76% | +$209K |
|
4249
CALL
Southern Copper
SCCO
$143B
| $481K | ﹤0.01% |
13,052
-22,546
| -63% | -$714K |
|
4250
Ascendis Pharma A/S
ASND
$16B
| $479K | ﹤0.01% |
3,241
+422
| +15% | +$57.9K |
|
Similar funds
Citigroup's Q2 2020 Portfolio in Review
As of Q2 2020, Citigroup held 7,909 positions worth $128B, up 16% from $111B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Citigroup withdrew a net $7.44B in Q2 2020, closing 313 positions and reducing 3,200 holdings. Its most notable exit was Allergan plc, an estimated $1.4B position sold in full.
By sector, the portfolio is most concentrated in Technology at 8.9% of assets, up from 6.7% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Citigroup opened a new position in Invesco Dorsey Wright Technology Momentum ETF worth $156M.
- Citigroup's largest Q2 2020 buy was Invesco Dorsey Wright Technology Momentum ETF: 4,800,363 shares worth $156M.
- Citigroup added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q2 2020, an estimated $552M increase.
- Citigroup's biggest Q2 2020 reduction was Alphabet (Google) Class A, cutting an estimated $396M.
- Citigroup fully exited Allergan plc in Q2 2020, selling an estimated $1.4B.
- Citigroup's ten largest holdings make up 23% of its $128B portfolio in Q2 2020.
- Citigroup opened 257 new positions and closed 313 in Q2 2020.
- Citigroup's portfolio value rose 16% quarter-over-quarter to $128B.
Based on Citigroup's 13F filing for Q2 2020, filed 12 Aug 2020.